Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3851225 | American Journal of Kidney Diseases | 2009 | 12 Pages |
Abstract
In HD patients, the MIS is associated with inflammation, nutritional status, quality of life, and 5-year prospective mortality. The mortality predictability of the MIS appears equal to serum interleukin 6 and somewhat greater than C-reactive protein levels. Controlled trials are warranted to examine whether interventions to improve the MIS can also improve clinical outcomes in HD patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mehdi MD, Rachelle RD, PhD, Jennifer RD, Deborah RD, Juhi RD, Sara RD, Csaba P. MD, Joel D. MD, Kamyar MD, MPH, PhD,